Today’s top gainers include the company Merck & Co., Inc. (NYSE:MRK) which is in the industry Drug Manufacturers – Major, gaining -0.44% today. In the last week its performance is 10.01%, and 18.53% for the past quarter. Currently, Merck & Co., Inc., MRK has a target price of *TBA, so today’s gain of -0.44% is a significant step towards its target price. The GAP today is therefore -0.77%.
Merck & Co., Inc. (NYSE:MRK), has a market cap of 177621.24, and is based in USA. Insider ownership is at 0.04%, and institutional ownership is 75.00%.
At the current price of 63.35, it has a dividend yield of 2.89%, and its target price is *TBA. This is with a profit margin of 13.00%, and total debt/equity of *TBA. Merck & Co., Inc. (NYSE:MRK) has a P/E of 34.85, as well as a forward P/E of 16.95.
With a current EPS of 1.83, and a forecasted EPS growth for next year at 0.59%,Merck & Co., Inc. (NYSE:MRK) has had a EPS growth for the past five years at 41.50%. For the next five years EPS growth is projected to be 5.35%.
Performance for the year is 13.00%. Since its IPO date on 1/2/1970, the total performance to date is 22.51%.
Volume today for Merck & Co., Inc. (NYSE:MRK), is 6244270, while its average volume is 10039.06. Whilst the total gain today was -0.44%, it did have a day high of -1.02%.
Volatility for this week has been at 3.43%, and 1.69% for the month. The 52-week low for Merck & Co., Inc., MRK has been 43.45%, while the 52-week-high has reached -1.02%.
Looking at its return of investments, which is 6.40%, and its return on assets is *TBA. Merck & Co., Inc. (NYSE:MRK) has an operating margin of 18.10%. With a sales growth of 0.60% quarter over quarter. Bearing in mind that Merck & Co., Inc., MRK is in the sector Healthcare, its long-term debt/equity is *TBA, and has a current ratio of *TBA and *TBA for quick ratio.
So what is the value of Merck & Co., Inc.? Well its PEG is 6.51, and the P/S is 4.5, along with a P/B of 4.02. Meanwhile it has a p/cash of *TBA.